期刊文献+

癌胚抗原联合血管生成素样蛋白2检测对胃癌诊断的临床意义 被引量:1

Clinical significance of the detection of carcinoembryonic antigen combined with vascular like protein 2 on the diagnosis of gastric cancer
下载PDF
导出
摘要 目的探讨联合检测癌胚抗原(CEA)和血管生成素样蛋白2(Ang-2)对胃癌的诊断价值。方法选取2012年2月至2015年2月本院收治的胃癌手术患者180例,同时选择我院健康体检者95例为对照组。检测两组受检者的血清CEA和Ang-2水平,分析胃癌患者术前血清CEA、Ang-2与其临床病理特征的相关性。结果胃癌组患者的血清CEA和Ang-2水平分别为(13.40±5.21)μg/L和(2.44±0.27)μg/L,均明显高于对照组的(2.14±0.58)μg/L和(0.85±0.10)μg/L,差异均有显著统计学意义(P<0.01);胃癌患者CEA和Ang-2的阳性率与低分化、Ⅲ~Ⅳ临床分期/淋巴结浸润显著相关(P<0.01),与患者的年龄、性别和原发部位无相关性(P>0.05);血清CEA联合Ang-2检测对胃癌诊断的特异性和灵敏度分别为96.71%和93.62%,均高于CEA或Ang-2单独检测。结论血清CEA和Ang-2联合检测能明显提高胃癌的诊断率。 Objective To investigate diagnostic value of the detection of carcinoembryonic antigen combined with vascular like protein 2 on the diagnosis of gastric cancer. Methods A total of 180 patients with gastric cancer(gastric cancer group) in our hospital from February of 2012 to February of 2015 were selected, and 95 health physical examination people were enrolled as control group. Serum levels of CEA and Ang-2 in two groups were detected. The relationship between serum Ang-2 and CEA in patients with gastric cancer and clinicopathological faclors was analyzed. Results Serum levels of CEA and Ang-2 in gastric cancer group were significantly higher than those of control group [(13.40±5.21) μg/L vs(2.14±0.58) μg/L,(2.44±0.27) μg/L vs(0.85±0.10) μg/L, P<0.01]. Positive rates of CEA and Ang-2 in patients with gastric cancer were significantly correlated with poorly differentiated,Ⅲ~Ⅳ in clinical stages, and lymph node infiltration(P<0.01). There was no correlation between age, sex, and primary site(P>0.05). The specificity and sensitivity of CEA combined with Ang-2 in the diagnosis of gastric cancer were 96.71% and 93.62%, respectively, which was significantly higher than single detection of serum CEA and Ang-2. Conclusion Combined detection of serum CEA and Ang-2 can significantly improve the diagnosis rate of gastric cancer.
出处 《海南医学》 CAS 2016年第11期1783-1785,共3页 Hainan Medical Journal
关键词 癌胚抗原 血管生成素样蛋白2 胃癌 诊断 Carcinoembryonic antigen Vascular like protein 2 Gastric cancer Diagnosis
  • 相关文献

参考文献2

二级参考文献21

  • 1余剑英.使用多肿瘤标志物蛋白质芯片诊断系统(C-12)检测胃癌的临床价值[J].中国医师杂志,2006,8(3):317-319. 被引量:5
  • 2Hoogervorst EM, van Steeg H, de Vries A. Nucleotide excision repair- and p53-deficient mouse models in cancer research [ J ]. Mutat Res,2005,574(1-2) :3-21.
  • 3Mattar R,Alves de Andrade CR, DiFavero GM, et al. Preoperative serum levels of CA 72-4, CEA, CA 19-9, and alpha-fetoprotein in patients with gastric cancer [ J]. Rev Hosp Clin Fac Med Sao Pau- lo, 2002,57 ( 3 ) : 89 -92.
  • 4Ucar E, Semerci E, Ustun H, et al. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer[ J]. Adv Ther,2008,25 ( 10 ) : 1075-1084.
  • 5Fernandes LL, Martins LC, Nagashima CA, et al. CA72-4 antigen levels in serum and peritoneal washing in gastric cancer. Correla- tion with morphological aspects of neoplasia [J]. Arq Gastroen- tero1,2007,44 ( 3 ) : 235-239.
  • 6龚建平,张宗明.外科领域的细胞分子生物学[M]//吴孟超,吴在德.黄家驷外科学.7版.北京:人民卫生出版社,2008:34-57.
  • 7Tahara T, Shibata T, Nakamura M, et al. Effect of IL-115 and TNF-α polymorphisms on the prognosis and survival of gastric cancer patients[ J ]. Clin Exp Med ,2011,11 (4) :211-217.
  • 8Jing Wang,Xiqiang Cai,Limin Xia,Jinfeng Zhou,Jing Xin,Muhan Liu,Xin Shang,Jian Liu,Xiaowei Li,Zhangqian Chen,Yongzhan Nie,Daiming Fan.??Decreased Expression of FOXJ1 is a Potential Prognostic Predictor for Progression and Poor Survival of Gastric Cancer(J)Annals of Surgical Oncology . 2015 (2)
  • 9Hong‐Wei Chen,Xiao‐Dong Huang,Hong‐Chen Li,Song He,Run‐Zhou Ni,Cui‐Hua Chen,Chen Peng,Gang Wu,Gui‐Hua Wang,Ying‐Ying Wang,Yun‐Hong Zhao,Yi‐Xin Zhang,Ai‐Guo Shen,Hui‐Min Wang.??Expression of FOXJ1 in hepatocellular carcinoma: Correlation with patients’ prognosis and tumor cell proliferation(J)Mol. Carcinog. . 2013 (8)
  • 10Siu MK,Wong ES,Kong DS,et al.Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of Ecadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers. Oncogeneadvance . 2013

共引文献13

同被引文献14

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部